Moses Abraham S, Taratula Olena R, Lee Hyelim, Luo Fangzhou, Grenz Tanner, Korzun Tetiana, Lorenz Anna St, Sabei Fahad Y, Bracha Shay, Alani Adam W G, Slayden Ov D, Taratula Oleh
College of Pharmacy, Oregon State University, 2730 SW Moody Avenue, Portland, OR, 97201, USA.
Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006, USA.
Small. 2020 May;16(18):e1906936. doi: 10.1002/smll.201906936. Epub 2020 Apr 6.
Endometriosis is a painful disorder where endometrium-like tissue forms lesions outside of the uterine cavity. Intraoperative identification and removal of these lesions are difficult. This study presents a nanoplatform that concurrently delineates and ablates endometriosis tissues using real-time near-infrared (NIR) fluorescence and photothermal therapy (PTT). The nanoplatform consists of a dye, silicon naphthalocyanine (SiNc), capable of both NIR fluorescence imaging and PTT, and a polymeric nanoparticle as a SiNc carrier to endometriosis tissue following systemic administration. To achieve high contrast during fluorescence imaging of endometriotic lesions, nanoparticles are constructed to be non-fluorescent prior to internalization by endometriosis cells. In vitro studies confirm that these nanoparticles activate the fluorescence signal following internalization in macaque endometrial stromal cells and ablate them by increasing cellular temperature to 53 C upon interaction with NIR light. To demonstrate in vivo efficiency of the nanoparticles, biopsies of endometrium and endometriosis from rhesus macaques are transplanted into immunodeficient mice. Imaging with the intraoperative Fluobeam 800 system reveals that 24 h following intravenous injection, nanoparticles efficiently accumulate in, and demarcate, endometriotic grafts with fluorescence. Finally, the nanoparticles increase the temperature of endometriotic grafts up to 47 °C upon exposure to NIR light, completely eradicating them after a single treatment.
子宫内膜异位症是一种疼痛性疾病,内膜样组织在子宫腔外形成病变。术中识别和切除这些病变很困难。本研究提出了一种纳米平台,该平台利用实时近红外(NIR)荧光和光热疗法(PTT)同时描绘和消融子宫内膜异位症组织。该纳米平台由一种染料硅萘酞菁(SiNc)组成,它既能进行近红外荧光成像又能进行光热疗法,还有一种聚合物纳米颗粒作为SiNc载体,在全身给药后靶向子宫内膜异位症组织。为了在子宫内膜异位症病变的荧光成像过程中实现高对比度,纳米颗粒在被子宫内膜异位症细胞内化之前被构建为无荧光的。体外研究证实,这些纳米颗粒在猕猴子宫内膜基质细胞内化后激活荧光信号,并通过与近红外光相互作用将细胞温度升高到53℃来消融细胞。为了证明纳米颗粒在体内的效果,将恒河猴的子宫内膜和子宫内膜异位症活检组织移植到免疫缺陷小鼠体内。使用术中Fluobeam 800系统成像显示,静脉注射后24小时,纳米颗粒有效地在子宫内膜异位移植组织中积累,并通过荧光进行标记。最后,纳米颗粒在暴露于近红外光后将子宫内膜异位移植组织的温度升高到47℃,单次治疗后将其完全根除。